Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2025-12-16 @ 12:20 PM
Study NCT ID:
NCT06320301
Status:
None
Last Update Posted:
2024-03-20 00:00:00
First Post:
2024-02-21 00:00:00
Brief Title:
Adebrelimab and a TKI in Combination With GEMOX in First-line Treatment of Advanced Biliary Tract Cancers (BTC)
Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization Data
Organization:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Class:
OTHER
Study ID:
SYSKY-2024-027-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Suzhou Suncadia Biopharmaceuticals Co Ltd | INDUSTRY |